JANA BEVILL: Open Payments
NPI 1912365495 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,891 in 81 payments from 33 companies in 2025. Trend: 2023 $1,088 · 2024 $1,636 · 2025 $1,891
Food & beverage: $1,671Education: $220
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 15 | $258 |
| Janssen Biotech, Inc. | 7 | $233 |
| AstraZeneca Pharmaceuticals LP | 6 | $123 |
| SOBI, INC | 2 | $123 |
| Merck Sharp & Dohme LLC | 5 | $115 |
| BeOne Medicines USA, Inc. | 3 | $70 |
| Astellas Pharma US Inc | 4 | $66 |
| PFIZER INC. | 3 | $65 |
| Alexion Pharmaceuticals, Inc. | 3 | $64 |
| ABBVIE INC. | 3 | $61 |
Products named: RYBREVANT, OPDIVO, KEYTRUDA, OPDUALAG, ULTOMIRIS, VENCLEXTA, Vyloy, SARCLISA.
Industry payments across GA — which companies pay providers there.
